PHO90 Antibody

What is PHO90 and what is its biological significance in yeast phosphate metabolism?

PHO90 is one of the low-affinity phosphate transporters in Saccharomyces cerevisiae (baker's yeast) that functions primarily when phosphate is abundant in the environment. It works in complementary fashion with other phosphate transporters in yeast: while the high-affinity transporters (Pho84 and Pho89) are active under phosphate starvation conditions, PHO90 and PHO87 serve as low-affinity transporters that function when phosphate is plentiful . PHO90 shares more than 60% sequence identity with PHO87 and contains a distinctive N-terminal SPX domain that plays crucial regulatory roles beyond simple phosphate uptake . The protein has a calculated molecular weight of approximately 154 kDa and plays an integral role in phosphate homeostasis within yeast cells. PHO90's regulatory functions are closely integrated with the PHO pathway, which controls phosphate acquisition and utilization in response to environmental phosphate availability .

What is the functional significance of the SPX domain in PHO90?

The SPX domain (named after yeast Syg1 and Pho81 and human XPR1) located at the N-terminus of PHO90 serves several critical regulatory functions:

• Limiting phosphate uptake velocity: Research with truncated versions of PHO90 shows that removal of the 375-amino-acid N-terminal SPX domain significantly increases phosphate-uptake rates (from 6.8 to 50.1 nmol Pi OD 600–1 min–1), suggesting that the SPX domain acts as an auto-inhibitory region .

• Suppressing phosphate efflux: The SPX domain prevents unregulated phosphate efflux through PHO90. Yeast strains lacking this domain show markedly increased phosphate release compared to strains with intact SPX domains .

• Regulating PHO pathway signaling: The SPX domain participates in the fine-tuning of the PHO pathway, a signaling cascade that regulates genes involved in phosphate acquisition and metabolism .

• Mediating protein-protein interactions: The SPX domain physically interacts with Spl2, a regulatory protein induced under phosphate limitation conditions, allowing for response-appropriate regulation of transport activity .

These findings indicate that the SPX domain functions as a critical regulatory module that coordinates phosphate uptake, storage, and utilization according to cellular needs and environmental conditions.

How does the PHO90 SPX domain interact with regulatory proteins?

The PHO90 SPX domain engages in specific protein-protein interactions that regulate its transport function. Research has revealed:

• Physical interaction with Spl2: Using both split-ubiquitin assays and co-immunoprecipitation techniques, researchers have demonstrated that the SPX domain of PHO90 physically interacts with the regulatory protein Spl2 . This interaction is physiologically significant, as it mediates inhibition of phosphate uptake through PHO90.

• Mechanism of action: When Spl2 is upregulated (which occurs under phosphate-limited conditions through the PHO pathway), it binds to the SPX domain of PHO90, inhibiting transporter activity. This represents a critical control mechanism that allows yeast cells to modulate their phosphate uptake according to environmental availability .

• Functional consequences: In strains where the SPX domain has been deleted, Spl2 overexpression fails to inhibit phosphate uptake, confirming that this domain is essential for Spl2-mediated regulation .

The interaction data is summarized in the following table:

These findings highlight how protein-protein interactions at the SPX domain constitute a crucial regulatory mechanism for phosphate transport in yeast.

What experimental techniques are most effective for studying PHO90 expression and localization?

Researchers investigating PHO90 expression and localization can employ several complementary techniques:

• Western blot analysis: Western blotting using PHO90-specific antibodies allows for quantification of protein levels and detection of truncated variants. As described in the literature, proteins can be extracted, separated by SDS-PAGE, and blotted for analysis. Hybridization with appropriate antibodies (such as against GFP tags in fusion proteins) allows for visualization and quantification of PHO90 levels .

• Confocal microscopy: For localization studies, GFP-tagged PHO90 constructs enable visualization of the protein's subcellular distribution using confocal microscopy. This approach has confirmed that both full-length PHO90 and truncated variants lacking the SPX domain (PHO90Δ375N) localize to the plasma membrane, indicating that the SPX domain is not required for proper membrane targeting .

• Northern blot analysis: For transcriptional studies, Northern blotting allows researchers to monitor PHO90 mRNA levels and compare them with other components of the phosphate transport system (such as PHO84) and the PHO pathway (like PHO5 and SPL2) .

• Functional transport assays: Measuring phosphate uptake rates in strains expressing wild-type or modified PHO90 provides functional data that complements expression and localization studies .

• Split-ubiquitin assays: This technique enables detection of protein-protein interactions involving PHO90, particularly its SPX domain. The assay utilizes reporter genes (lacZ, HIS3, URA3) to assess interactions between bait and prey constructs .

These methods collectively provide a comprehensive toolkit for investigating PHO90 biology at both the molecular and cellular levels.

How can truncated versions of PHO90 be generated to study domain-specific functions?

Creating truncated versions of PHO90 is a powerful approach for investigating domain-specific functions, particularly of the regulatory SPX domain. Based on published methodologies:

• Genomic modification: N-terminal truncations can be generated directly in the genome of Saccharomyces cerevisiae. For studying the SPX domain, researchers have successfully removed 375 amino acids from the N-terminus of PHO90, encompassing the entire SPX domain .

• GFP fusion constructs: Generating GFP-tagged versions of both full-length and truncated PHO90 facilitates monitoring of protein expression, stability, and localization. This approach has confirmed that the removal of the SPX domain does not affect protein levels or plasma membrane localization .

• Plasmid-based expression systems: For controlled expression studies, both wild-type and truncated PHO90 variants can be expressed from plasmids under native or heterologous promoters. Overexpression systems have proven particularly useful for evaluating the functional consequences of domain deletions .

• Validation: It is essential to verify that the truncated proteins retain their basic functionality and localization. Western blotting, confocal microscopy, and functional transport assays should be employed to confirm that any observed phenotypic differences are specifically due to the domain deletion rather than protein misfolding or mistargeting .

This systematic approach to generating and validating truncated PHO90 variants has been instrumental in defining the auto-inhibitory and regulatory functions of the SPX domain in phosphate transport.

What methodological considerations are important when studying phosphate efflux mediated by PHO90?

Investigating phosphate efflux mediated by PHO90 requires careful experimental design and consideration of several methodological factors:

These methodological considerations enable researchers to establish that PHO90 can mediate phosphate efflux when not regulated by Spl2 and the SPX domain, providing insight into the bidirectional nature of this transporter.

How can researchers best utilize antibodies to study PHO90 function and regulation?

Antibodies against PHO90 are valuable tools for investigating this transporter's function and regulation. Researchers should consider the following approaches:

• Selection of appropriate antibodies: When studying PHO90 in Saccharomyces cerevisiae, researchers should select antibodies raised against the target strain (e.g., ATCC 204508/S288c) . Both polyclonal and monoclonal antibodies have applications in PHO90 research, with polyclonal antibodies offering broader epitope recognition .

• Western blot analysis: PHO90 antibodies enable quantitative assessment of protein expression levels. In studies comparing wild-type and modified PHO90 variants, Western blotting with appropriate controls (such as Hxk antibodies for loading standardization) allows for accurate quantification of relative protein levels .

• Co-immunoprecipitation: For studying protein-protein interactions involving PHO90, antibodies can be used in co-immunoprecipitation experiments. This approach has successfully demonstrated the interaction between the SPX domain and regulatory proteins like Spl2 .

• Immunolocalization: Antibodies can be used for immunofluorescence microscopy to determine the subcellular localization of PHO90 in various genetic backgrounds and under different phosphate conditions. This complements studies using GFP-tagged variants .

• Validation strategies: When working with new antibodies against PHO90, researchers should validate specificity using multiple approaches, including detection of overexpressed protein, absence of signal in deletion strains, and consistency with results from tagged constructs .

• Combining antibody-based approaches with functional assays: The most informative studies combine antibody-based detection of PHO90 with functional assays measuring phosphate transport, enabling correlations between protein levels/modifications and transport activity .

These strategies maximize the utility of PHO90 antibodies in comprehensive investigations of transporter biology.

What experimental approaches can distinguish between the functions of PHO87 and PHO90?

Distinguishing between the functions of the closely related low-affinity phosphate transporters PHO87 and PHO90 (which share >60% sequence identity) requires strategic experimental design:

• Genetic approaches: Creating single and double deletion strains (pho87Δ, pho90Δ, pho87Δ pho90Δ) allows researchers to attribute specific phenotypes to each transporter. Additional deletions of other phosphate transporters can further isolate the functions of PHO87 versus PHO90 .

• Domain-specific modifications: While both transporters contain N-terminal SPX domains, creating parallel truncations (e.g., pho87Δ375N and pho90Δ375N) enables comparison of the regulatory functions of these domains in each protein context .

• Phosphate transport kinetics: Detailed kinetic analysis of phosphate uptake in strains expressing only PHO87 or only PHO90 can reveal differences in transport parameters (Km, Vmax) and regulatory properties .

• Response to Spl2 regulation: Both transporters are regulated by Spl2, but potentially with different sensitivities. Controlled expression of Spl2 in strains expressing only PHO87 or only PHO90 can uncover differences in regulatory mechanisms .

• Phosphate efflux studies: Comparing phosphate efflux capacities between strains expressing only PHO87 or only PHO90 (with and without SPX domains) can identify transporter-specific contributions to bidirectional phosphate movement .

• Transcriptional effects on PHO pathway: Examining how overexpression of each transporter affects PHO pathway transcription can reveal differences in their regulatory impact on phosphate homeostasis .

The combined results from these complementary approaches enable researchers to delineate the specific contributions of PHO87 and PHO90 to yeast phosphate transport and homeostasis.

How does the SPX domain of PHO90 affect intracellular phosphate distribution and storage?

The SPX domain plays a crucial role in regulating not only phosphate uptake but also its intracellular distribution and storage:

• Total phosphate and polyphosphate levels: Strains expressing PHO90 without its SPX domain (pho90Δ375N) exhibit higher total phosphate (Ptot) and polyphosphate (polyP) content compared to strains with full-length PHO90, indicating that the SPX domain normally restricts phosphate accumulation .

• Cytosolic versus stored phosphate: The SPX domain influences the balance between cytosolic inorganic phosphate (Pi) and stored forms (primarily polyP). This distribution has significant implications for cellular metabolism and signaling .

The following table summarizes the effects of SPX domain deletion and Spl2 expression on phosphate parameters:

• PHO pathway regulation: Intriguingly, the transcriptional regulation of the PHO pathway correlates with total phosphate and polyphosphate content but not with cytosolic Pi levels. This suggests that the signal for PHO pathway regulation is not free cytosolic Pi but likely another organic phosphate form, possibly inositol pyrophosphate .

• Long-term phosphate retention: In stationary phase, strains lacking the PHO90 SPX domain show decreased cellular phosphate content to levels below those of wild type, indicating that the SPX domain is critical for long-term phosphate retention .

These findings highlight the complex role of the PHO90 SPX domain in coordinating phosphate uptake, storage, and utilization to maintain proper phosphate homeostasis across different growth conditions.

What controls should be included when performing phosphate transport assays with PHO90?

When conducting phosphate transport assays to study PHO90 function, researchers should include several essential controls:

• Strain background controls:

  • Wild-type strain (positive control)

  • Complete phosphate transporter deletion strain (pho84Δ pho87Δ pho89Δ pho90Δ) as a negative control

  • Strains expressing only PHO90 (pho84Δ pho87Δ pho89Δ) to isolate PHO90-specific transport

• Protein expression verification:

  • Western blot analysis to confirm comparable expression levels between wild-type and modified PHO90 variants

  • Loading controls (e.g., Hxk antibodies) for normalization

• Localization confirmation:

  • Microscopy (confocal or fluorescence) to verify proper membrane localization of PHO90 variants

  • Plasma membrane marker co-localization

• Kinetic parameter controls:

  • Range of phosphate concentrations (typically 0-10 mM) to determine Km and Vmax values

  • Time course measurements to establish linear uptake phase

• Regulatory protein controls:

  • Strains with and without Spl2 overexpression to assess regulatory effects

  • Empty vector controls for overexpression constructs

• Domain function controls:

  • Parallel assays with full-length PHO90 and SPX domain-deleted variants (pho90Δ375N)

  • Complementation tests with isolated SPX domains

• Physiological state standardization:

  • Consistent growth phase (typically mid-log)

  • Defined pre-incubation conditions (phosphate-rich or phosphate-limited)